United Therapeutics (UTHR) Tops Q3 EPS by 85c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $555.91 +1.60%
EPS Growth %: +11.9%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
CRMT, More
EPS Growth %: +11.9%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $4.91, $0.85 better than the analyst estimate of $4.06. Revenue for the quarter came in at $516 million versus the consensus estimate of $493.81 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
- RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
